Syneron Medical Ltd (ELOS) Reports In-Line Q1 EPS

Syneron Medical Ltd (NASDAQ: ELOS) reported Q1 EPS of $0.04, in-line with the analyst estimate of $0.04. Revenue for the quarter came in at $56.8 million versus the consensus estimate of $55.5 million.

For earnings history and earnings-related data on Syneron Medical Ltd (ELOS) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Boxlight Corporation (BOXL) Tops Q2 EPS by 2050c
• DA Davidson Reiterates Neutral Rating on Nebius Group (NBIS)